首页> 美国卫生研究院文献>Tissue Engineering. Part A >Characterization of the Enhanced Bone Regenerative Capacity of Human Periodontal Ligament Stem Cells Engineered to Express the Gene Encoding Bone Morphogenetic Protein 2
【2h】

Characterization of the Enhanced Bone Regenerative Capacity of Human Periodontal Ligament Stem Cells Engineered to Express the Gene Encoding Bone Morphogenetic Protein 2

机译:表征表达编码骨形态发生蛋白2基因的人牙周膜干细胞增强的骨再生能力的表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human periodontal ligament stem cells (hPDLSCs) are considered an appropriate cell source for therapeutic strategies. The aims of this study were to investigate the sustainability of bone morphogenetic protein 2 (BMP2) secretion and the bone regenerative capacity of hPDLSCs that had been genetically modified to express the gene encoding BMP2 (BMP2). hPDLSCs isolated from healthy third molars were transduced using replication-deficient recombinant adenovirus (rAd) encoding BMP2 (hPDLSCs/rAd-BMP2), and the cellular characteristics and osteogenic potentials of hPDLSCs/rAd-BMP2 were analyzed both in vitro and in vivo. hPDLSCs/rAd-BMP2 successfully secreted BMP2, formed colonies, and expressed immunophenotypes similar to their nontransduced counterparts. As to their osteogenic potential, hPDLSCs/rAd-BMP2 formed greater mineralized nodules and exhibited significantly higher levels of expression of BMP2 and the gene encoding alkaline phosphatase, and formed more and better quality bone than other hPDLSC-containing or recombinant human BMP2-treated groups, being localized at the initial site until 8 weeks. The findings of the present study demonstrate that hPDLSCs/rAd-BMP2 effectively promote osteogenesis not only in vitro but also in vivo. The findings also suggest that hPDLSCs can efficiently carry and deliver BMP2, and that hPDLSCs/rAd-BMP2 could be used in an attractive novel therapeutic approach for the regeneration of deteriorated bony defects.
机译:人牙周膜干细胞(hPDLSC)被认为是治疗策略的合适细胞来源。这项研究的目的是调查的骨形态发生蛋白2(BMP2)分泌的可持续性和经过基因修饰以表达编码BMP2(BMP2)的hPDLSCs的骨再生能力。从健康的第三磨牙中分离出的hPDLSCs使用编码BMP2(hPDLSCs / rAd-BMP2)的复制缺陷型重组腺病毒(rAd)转导,并在体内和体外分析了hPDLSCs / rAd-BMP2的细胞特征和成骨潜能。 hPDLSCs / rAd-BMP2成功分泌BMP2,形成菌落,并表达类似于其非转导对应物的免疫表型。关于其成骨潜能,hPDLSCs / rAd-BMP2形成更大的矿化结节,并表现出更高水平的BMP2表达和碱性磷酸酶编码基因,并且比其他包含hPDLSC或重组人BMP2处理的组形成更多更好的骨质,将其本地化到最初的网站,直到8周。本研究的发现表明,hPDLSCs / rAd-BMP2不仅在体外而且在体内都有效地促进了成骨作用。这些发现还表明,hPDLSCs可以有效地携带和递送BMP2,并且hPDLSCs / rAd-BMP2可以用于吸引人的新颖治疗方法中,以再生恶化的骨缺损。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号